WARBY PARKER CL.A -,0001 Aktie Logo
US93403J1060
A3C49J
WRBY

WARBY PARKER CL.A -,0001 Aktie

Loading quotes...

Forecast

The analysts' average price target is €26.34 (+24.42%). The median is €25.82 (+21.97%).

Buy
  9
Hold
  7
Sell
  0

  • Blacksheep launches in US with prescription glasses from $3.98, targets Warby Parker and Luxottica

    Blacksheep, led by CEO Pierre Wizman, is entering the U.S. market offering prescription glasses starting at $3.98 and selling designer frames for $1 with low-cost lenses, claiming on-demand production and minimal margins by cutting out middlemen. Wizman accuses incumbents of massive markups and vows to disrupt Luxottica’s dominance and Warby Parker’s pricing, while Warby Parker defends its value-driven, feature-rich products. Industry peers express skepticism about the feasibility and quality of such low-priced eyewear and note manufacturing and material costs as key differentiators. » More on forbes.com


  • Warby Parker: shareholders elect directors, ratify Ernst & Young and approve compensation

    At the annual meeting shareholders elected Dave Gilboa, Youngme Moon and Ronald Williams to the board (term to 2029), ratified Ernst & Young LLP as independent auditors for 2026 and approved, in a non-binding advisory vote, the compensation of the named executive officers. About 95.97% of the voting power was represented. Warby Parker also reported Q1 results with EPS of $0.03 (below expectations) and revenue of $242.45 million (slightly above expectations), and announced an "Intelligent Eyewear" collaboration with Google and Samsung. » More on de.investing.com


  • Warby Parker misses earnings forecast, revenue slightly above expectations

    Warby Parker reported Q1 2026 EPS of $0.03 versus $0.15 expected, while revenue of $242.45 million topped expectations of $239.82 million by 1.1%. Retail sales grew 13.6% year‑over‑year, while e‑commerce declined after the discontinuation of the Home-Try-On program. Adjusted gross margin and profitability are under pressure; adjusted EBITDA was $29.6 million (margin 12.2%). The company reaffirmed its full-year revenue guidance of $959–976 million and plans to invest in the planned launch of AI glasses in partnership with Google and Samsung. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2022, WARBY PARKER CL.A -,0001 Aktie has already paid €7.07 in dividends. The last payout was in April 2022.

Financials

In the last quarter, WARBY PARKER CL.A -,0001 Aktie had revenue of €206.36M and net profit of €4.07M
(EUR) Jun 2026
YoY
Revenue 206.36M 13.40%
Gross profit 119.56M 24.05%
Net profit 4.07M 373.75%
EBITDA 30.8M 265.05%

Fundamentals

Metric Value
Market capitalization
€2.64B
Number of shares
122.72M
52-week high/low
€26.68 - €12.88
Dividends No
Beta
1.93
P/E ratio
379.94
PEG ratio
0.10
P/B ratio
7.90
P/S ratio
3.37

Company profile

Warby Parker Inc. stellt Brillenprodukte her. Das Unternehmen bietet Brillen, Sonnenbrillen, lichtempfindliche Linsen, Blaulichtfilter-Linsen und Kontaktlinsen sowie Zubehör wie Etuis, Linsen-Kits mit Anti-Beschlag-Spray, Etuis und Anti-Beschlag-Linsenspray. Das Unternehmen bietet über seine Einzelhandelsgeschäfte, seine Website und seine mobilen Apps auch Augenuntersuchungen und Sehtests direkt für Verbraucher an. Am 16. Mai 2022 hatte das Unternehmen 160 Einzelhandelsgeschäfte in den Vereinigten Staaten und Kanada. Das Unternehmen war früher als JAND, Inc. bekannt und änderte im Juni 2021 seinen Namen in Warby Parker Inc. um. Warby Parker Inc. wurde im Jahr 2009 gegründet und hat seinen Hauptsitz in New York, New York.

Name
WARBY PARKER CL.A -,0001 Aktie
CEO
Neil Harris Blumenthal
Headquarters New York City, ny
USA
Website
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO
09/29/2021
Employees 4,036

Ticker symbols

Exchange Symbol
NYSE
WRBY
🍪

Parqet  uses cookies. Learn more